Audicin Raises $1.9 Million to Enhance Neurotech Offerings
Audicin, a Finnish neurotech startup, has successfully secured $1.9 million in a recent funding round. The round, which remains undisclosed in terms of its series designation, was led by Petteri Lahtela, known for his involvement in wearable technology. Virpi Tuomivaara also participated as an investor.
What Audicin Does
Audicin offers a unique approach to mental well-being through its innovative use of binaural beats. Users can experience the effects of Audicin's technology within minutes by downloading their app and pressing play. This approach aims to aid nervous system recovery and improve overall mental health.
Leadership at Audicin
The company is steered by Founder and CEO Laura Avonius, alongside Co-founder and Chief Scientist Victoria Williamson. Together, they drive Audicin's mission to integrate neurotech solutions into everyday life.
Strategic Use of Funds
While the company has not specified detailed plans for the new funds, the investment will likely support the integration of their neurotech solutions into wearable technology and apps. This aligns with Lahtela's background and interest in the wearable tech space.
Investors' Background
Petteri Lahtela, a key figure behind this funding round, has a history of engagement with technology that enhances personal health monitoring. His involvement suggests a strong alignment with Audicin's goals of leveraging technology for mental health improvements.
As Audicin continues to develop its products, the support from investors like Lahtela and Tuomivaara is expected to accelerate the company's growth and innovation in the neurotech sector.